Cologne, Germany, March 18, 2013. Today, Direvo Industrial Biotechnology GmbH (Direvo) announced the successful closure of a financing round of three and a half million Euro to fund the sustainable growth of the company.
All current major investors participated in this third financing round since the founding of Direvo, a spin-off from Direvo Biotech AG, in the year 2008. The capital will be used to get the platform technologies BluCon® and BluZy® ready for the market.
Jorg Riesmeier, Chief Executive Officer of Direvo, said: “We are pleased to have closed this financing round to accelerate the market maturity of our products. We are also very proud that all of our existing investors have committed again. This underlines the investors’ belief in our team, the satisfaction with the things we have achieved so far and the trust to manage the up-coming challenges in the markets. Direvo is well prepared for a successful market entrance.”
About Direvo Industrial Biotechnology GmbH:
Direvo is a biotechnology company focusing on the biomass conversion industry. Direvo identifies bottlenecks and weaknesses in current industrial processes in this sector and develops and implements biology-based solutions together with large and small industrial partners. Direvo’s products are newly designed enzymes and high quality microorganisms that provide easy-to-implement and cost-effective solutions. Direvo’s contributions strengthen the competitiveness and the profitability of the partners while supporting them to make the future cleaner, greener and safer. More information about Direvo is available on www.direvo.com.
DIREVO Industrial Biotechnology GmbH
50829 Köln (Cologne)
Phone +49 221-47448-101
Fax +49 221-47448-111